Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (1)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1190)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (160)
Global (1)
South-East Asia (11)
Western Pacific (39)
Diseases
COVID-19 (1589)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (13)
Moderate (9)
Low (130)
Critically low (729)
Not applicable (309)
1589 results found
2021
∙
ATAGI
Clinical guidance on use of COVID-19 vaccine in Australia in 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Co-administration of COVID-19 vaccines with other vaccines (simultaneous vaccination)
2021
∙
Public Health England
comparison between 1 and 2 dose prioritisation for a fixed number of doses
2021
∙
ATAGI
COVID-19 vaccination : ATAGI decision guide for people receiving palliative care or end-of-life care - 4 May 2021
2021
∙
ATAGI
COVID-19 vaccination : ATAGI guidance on the use of multi-dose vials for COVID-19 vaccination - 4 May 2021
2021
∙
CCVS
COVID-19 vaccination for children
2021
∙
Health Council of the Netherlands
COVID-19 vaccination: BioNTech/Pfizer
2021
∙
Health Council of the Netherlands
COVID-19 vaccination: Janssen vaccine
2021
∙
Health Council of the Netherlands
COVID-19 vaccination: The Moderna vaccine and the vaccination strategy
2021
COVID-19 vaccination: The Moderna vaccine and the vaccination strategy
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
